Top Key Companies for Emerging Infectious Disease Market: BD, Abbott, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex, Gen-Probe, Cepheid, Hologic.
Global Emerging Infectious Disease Market Size was estimated at USD 4897.2 million in 2022 and is projected to reach USD 7349.38 million by 2028, exhibiting a CAGR of 7% during the forecast period.
Global Emerging Infectious Disease Market Overview And Scope:
The Global Emerging Infectious Disease Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Emerging Infectious Disease utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Emerging Infectious Disease Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Emerging Infectious Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Emerging Infectious Disease market.
Global Emerging Infectious Disease Market Segmentation
By Type, Emerging Infectious Disease market has been segmented into:
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
By Application, Emerging Infectious Disease market has been segmented into:
Clinical Laboratories
Diagnostic Centers
Others
Regional Analysis of Emerging Infectious Disease Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Emerging Infectious Disease Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Emerging Infectious Disease market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Emerging Infectious Disease market.
Top Key Companies Covered in Emerging Infectious Disease market are:
BD
Abbott
BioMerieux
Danaher
Orasure
Qiagen
Quidel
Sysmex
Gen-Probe
Cepheid
Hologic
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Emerging Infectious Disease Market by Type
5.1 Emerging Infectious Disease Market Overview Snapshot and Growth Engine
5.2 Emerging Infectious Disease Market Overview
5.3 AIDS
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 AIDS: Geographic Segmentation
5.4 Ebola
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Ebola: Geographic Segmentation
5.5 SARS
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 SARS: Geographic Segmentation
5.6 Avian Flu
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Avian Flu: Geographic Segmentation
5.7 Chikungunya
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Chikungunya: Geographic Segmentation
5.8 Zika
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Zika: Geographic Segmentation
5.9 Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Others: Geographic Segmentation
Chapter 6: Emerging Infectious Disease Market by Application
6.1 Emerging Infectious Disease Market Overview Snapshot and Growth Engine
6.2 Emerging Infectious Disease Market Overview
6.3 Clinical Laboratories
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Clinical Laboratories: Geographic Segmentation
6.4 Diagnostic Centers
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Diagnostic Centers: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Emerging Infectious Disease Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Emerging Infectious Disease Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Emerging Infectious Disease Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BD
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 ABBOTT
7.4 BIOMERIEUX
7.5 DANAHER
7.6 ORASURE
7.7 QIAGEN
7.8 QUIDEL
7.9 SYSMEX
7.10 GEN-PROBE
7.11 CEPHEID
7.12 HOLOGIC
Chapter 8: Global Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 AIDS
8.2.2 Ebola
8.2.3 SARS
8.2.4 Avian Flu
8.2.5 Chikungunya
8.2.6 Zika
8.2.7 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Clinical Laboratories
8.3.2 Diagnostic Centers
8.3.3 Others
Chapter 9: North America Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 AIDS
9.4.2 Ebola
9.4.3 SARS
9.4.4 Avian Flu
9.4.5 Chikungunya
9.4.6 Zika
9.4.7 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Clinical Laboratories
9.5.2 Diagnostic Centers
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 AIDS
10.4.2 Ebola
10.4.3 SARS
10.4.4 Avian Flu
10.4.5 Chikungunya
10.4.6 Zika
10.4.7 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Clinical Laboratories
10.5.2 Diagnostic Centers
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 AIDS
11.4.2 Ebola
11.4.3 SARS
11.4.4 Avian Flu
11.4.5 Chikungunya
11.4.6 Zika
11.4.7 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Clinical Laboratories
11.5.2 Diagnostic Centers
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 AIDS
12.4.2 Ebola
12.4.3 SARS
12.4.4 Avian Flu
12.4.5 Chikungunya
12.4.6 Zika
12.4.7 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Clinical Laboratories
12.5.2 Diagnostic Centers
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 AIDS
13.4.2 Ebola
13.4.3 SARS
13.4.4 Avian Flu
13.4.5 Chikungunya
13.4.6 Zika
13.4.7 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Clinical Laboratories
13.5.2 Diagnostic Centers
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Emerging Infectious Disease Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 AIDS
14.4.2 Ebola
14.4.3 SARS
14.4.4 Avian Flu
14.4.5 Chikungunya
14.4.6 Zika
14.4.7 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Clinical Laboratories
14.5.2 Diagnostic Centers
14.5.3 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Emerging Infectious Disease Scope:
|
Report Data
|
Emerging Infectious Disease Market
|
|
Emerging Infectious Disease Market Size in 2025
|
USD XX million
|
|
Emerging Infectious Disease CAGR 2025 - 2032
|
XX%
|
|
Emerging Infectious Disease Base Year
|
2024
|
|
Emerging Infectious Disease Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
BD, Abbott, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex, Gen-Probe, Cepheid, Hologic.
|
|
Key Segments
|
By Type
AIDS
Ebola
SARS
Avian Flu
Chikungunya
Zika
Others
By Applications
Clinical Laboratories
Diagnostic Centers
Others
|
